Treating HIV-Associated Lymphoma
Joseph Alvarnas, MD, Director of Medical Quality, associate clinical professor, City of Hope, discusses the treatment of HIV-associated lymphoma.
Clinical Pearls
Joseph Alvarnas, MD, Director of Medical Quality, associate clinical professor, City of Hope, discusses the treatment of HIV-associated lymphoma.
- The most appropriate way to treat patients with HIV and lymphoma has been a quandary for years.
- This study looked at autologous hematopoietic stem cell transplantation for the treatment of patients with chemotherapy-sensitive, relapsed/refractory HIV-associated lymphoma.
- Estimated probability of one-year OS was 86.6%.
<<<
Recent Videos
Related Content
Examining the Non-Hodgkin Lymphoma Treatment Paradigm
July 15th 2022Podcast
In season 3, episode 6 of Targeted Talks, Yazan Samhouri, MD, discusses the exciting new agents for the treatment of non-Hodgkin lymphoma, the clinical trials that support their use, and hopes for the future of treatment.
Listen
